# An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada

> **NCT02688075** · — · COMPLETED · sponsor: **Janssen Inc.** · enrollment: 538 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02688075
- **Lead sponsor:** Janssen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-13
- **Primary completion:** 2017-08-17
- **Final completion:** 2017-08-17
- **Target enrollment:** 538 (ACTUAL)
- **Last updated:** 2017-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02688075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02688075, "An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02688075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*